What was Pfizer thinking? Another family, Another drug, Another murder-suicide...



April 7, 2011 - Killer dad Andrew Case was taking powerful anti-smoking drugs, Was this man informed when he went to the doctor to get something to help him stop smoking, that chantix tops the list of “31 prescription drugs associated with violence”??? 33-year-old’s body Andrew Case, along with his wife Vicki, 31, and two little girls Phoebe, two, and Nereya, 18 months, were discovered at their home in Fordingbridge, Hampshire, on Monday July 26 2010.

Of the 31 drugs, “the worst offender with the strongest association to uncontrollable, murderous violence–within days of ingesting the drug–is the smoking cessation drug, Chantix (varenicline), which increases dopamine: it ranks 18.0 in the proportional reporting ratio (PRR) with 408 cases of violence–including murder. There are two other smoking cessation drugs that do NOT pose serious risks of violence.”

Refeence: Killer dad Andrew Case was taking powerful anti-smoking drugs, leoniefennell.wordpress.com&, 4//2011.

Some Chantix (Champix) related news briefs:
Chantix (Champix) risks out weigh the benefits - the story of Dr. Brenda Wells..:
Japan - demand for Chantix (Champix) soars while more and more lawsuits pile up in the U.S..;
Champix (Chantix) - Health Canada issues stronger warnings..;
Champix (Chantix) - Canada class-action lawsuit started..;
Champix (Chantix) - more serious psychiatric reactions and death..;
Smoking Cessation - Chantix (Champix) vs. Cold Turkey..;
Chantix - Pfizer faces three lawsuits surely many more to come..;
Champix (Chantix) - the risks are greater then the benefits..;
Chantix - another wrongful death lawsuit filed..;
Anti-smoking drugs (non-nicotine) - Chantix and Zyban to carry mental health warnings..;
Another Chantix Warning in Canada..;
Operators of any form of transportation warned on the use of Pfizer's smoking-cessation drug Chantix..;
Pfizer Changes Chantix Label..;
Chantix Reports of Suicidal Thoughts and Aggressive and Erratic Behavior..;

0 comments: